NEWS ARCHIVE

Category: Press Release

Company surpasses $3M in accepted investments  CHICAGO – September 16, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, announced it has modified its Regulation A+ (Mini-IPO) offering following a successful September re-launch. BIOLIFE4D has raised more than $3M in equity crowdfunding investments since February of 2018. …

Pioneering biotech company reaches significant milestone, using proprietary bioink to successfully 3D bioprint a mini-heart with full structure of a whole heart, including chambers and ventricles  CHICAGO – September 9, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully demonstrated its…

Company surpassed $2M in accepted investments during highly successful first equity crowdfunding event; expects to make significant scientific announcement in the near future CHICAGO – September 6, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched its second Regulation A+…

Company names Dr. Michael Davidson, Mr. Stephen Simes, Dr. Mark Weinberg, and Mr. Bruce Werner as strategic advisors CHICAGO – January 28, 2019 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a Management Advisory Board to offer strategy and leadership…

Pioneering biotech company reaches significant milestone well ahead of 6-8 month development time, successfully 3D bioprinting a human cardiac patch, as it seeks to produce full human hearts viable for transplant CHICAGO – June 25, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today…

Company surpasses $1M in accepted investments; expects to make significant scientific announcement in the near future CHICAGO – June 22, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying its Regulation A+ (Mini-IPO) offering, effective June 22, 2018, following…

Houston location provides access to state-of-the-art equipment and support, and close proximity to world class academic research facilities within local university medical and science centers, as Company continues development of groundbreaking bioprinting technology CHICAGO – May 29, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for…

Agreement provides access to world class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities, as Company continues development of groundbreaking bioprinting technology CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a Laboratory…

Pioneering biotech company seeks investors in innovative technology to enable the 3D bioprinting of human hearts viable for transplant; investors of $100,000 or more will witness initial heart transplant firsthand CHICAGO – February 1, 2018 – BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced…

Healthcare 3D printing market projected to reach $2.2B by 2024, driven by applications in tissue engineering and regenerative medicine; Company prepares to take investments for its pioneering 3D bioprinting technology. CHICAGO, Jan. 17, 2018  — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on the…

Build a Heart. Save a life.

Scroll Up